A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)
EHA Library, Rachael F. Grace,
422422
ZANUBRUTINIB AND ELTROMBOPAG AS SECOND-LINE TREATMENTS FOR PATIENTS WITH IMMUNE THROMBOCYTOPENIA: AN OPEN-LABEL, RANDOMIZED, CONTROLLED, PHASE 2 TRIAL
EHA Library, Chencong Wang,
422421
EFFICACY AND SAFETY OF THE SYK INHIBITOR SOVLEPLENIB (HMPL-523) IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN CHINA (ESLIM-01): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY
EHA Library, Renchi Yang,
422420